Raymond James & Associates Amyris, Inc. Call Options Transaction History

Raymond James & Associates

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Jul 25, 2023	SELL	$0.58 - $1.3 $9,628 - $21,580	-16,600 Reduced 94.32%	1,000 $1,000
Q1 2023 Apr 14, 2023	SELL	$1.09 - $1.82 $22,672 - $37,856	-20,800 Reduced 54.17%	17,600 $23,000
Q4 2022 Feb 08, 2023	SELL	$1.52 - $3.39 $23,712 - $52,884	-15,600 Reduced 28.89%	38,400 $58,000
Q3 2022 Oct 25, 2022	SELL	$1.7 - $4.05 $16,660 - $39,690	-9,800 Reduced 15.36%	54,000 $22,000
Q2 2022 Aug 12, 2022	BUY	$1.6 - $5.07 $73,920 - $234,234	46,200 Added 262.5%	63,800 $16,000
Q4 2021 Feb 08, 2022	SELL	$5.0 - $14.85 $152,000 - $451,440	-30,400 Reduced 63.33%	17,600 $39,000
Q3 2021 Nov 02, 2021	BUY	$12.13 - $16.99 $582,240 - $815,519	48,000 New	48,000 $221,000

230K

Ticker AMRS
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 324,860,000
Market Cap $3.25M
Description
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.